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The effect of PVV A treatment on normal human serum 
(NHS), on isolated PMN, or on C3-deficient guinea pigs and 
con genic (C3-competent) control animals was tested. At a 
concentration of 0.1 or 1 mM/l 8-MOP and UVA doses of 
5-30 ]/cm', PUVA failed to induce any detectable C3-
cleavage in NHS. Furthermore, when the complement (C) 
activation in NHS had been induced before or after PUV A 
treatment by various methods, PVV A did not modulate the 
extent of C3-cleavage. PVV A did not affect the viability of 
isolated PMN, nor did it induce a release of LDH or elastase. 
No differences between C3-deficient and C-competent 
T reatmem with 8-methoxypsoralen (8-MOP) and sub-sequent exposure to UVA irradiation, i.e., PUVA, is widely and effectively used in therapy of psoriasis, lichen ruber, mycosis fungoides, and other derma-toses. One of the most frequem side effects is a de-
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Abbreviations; 
8-MOP: 8-methoxypsoralen 
AnC: avidin-biotin-complex 
APAAP: alkaline phosphause/anti-a.1kaline phosphatase 
C: comple:ment 
DMSO: dimethylsulfoxide: 
EDTA: e:rhylenediaminetetraacetic acid 
ELISA: enzyme-linked immunosorbcnt assay 
FITC; Ruoresceinisothiocyanat 
HUSA: Hank's balanced salt solution wirh bovine serum a.1bumin 
without calcium 
IF: immunofluorescence 
LDH: lactic dehydrogenase 
PBS: phosphate-buffered salIne 
PMN: polymorphonuclear leukocytes 
PUVA: 8-melhoxypsoralen and ultraviolet A radiation 
RIA: radioimmunoassay 
UVA: ultraviolet A 
UVB: ultraviolet B 
UVC: ultraviolet C 
XIE: crossed immunoelectrophoresis 
guinea pig skin exposed to PUV A were observed in erythema 
or histologic responses. Immunohistologic examination of 
specimens from normal guinea pigs revealed C3b and C3d 
deposits on necrotic keratinocytes, findings restricted to the 
PUVA-tccated areas. Necrosis ofkeratinocytes was present in 
skin specimens of C3-deficient arumals hom PVV A-treated 
sites to a similar extent. However, deposits of C3-related 
antigens were completely absent there. From these observa-
tions, we suggest that the induction of phototoxic erythema 
following PVVA treatment is independent of complement. 
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layed erythema. which represents an interesting tool for studies of 
mechanisms of cutaneous inflammation in vivo. 
Acme phototoxiciry due to psoralen and UV A has severa] charac~ 
teristics which distinguish it from cutaneous responses to UVB-ra-
diation (sunburn). Erythema caused by PUV A treatment has a 
longer latent period between irradiation and onset, with its maxi~ 
mum at 48 - 72 h. The mechanism leading to the development of 
PUVA phototoxicity and the mediators which are liberated have 
not yet been identified [1]. Cyclooxygenase inhibitors like indo-
methacin have been shown to inhibit UVB-erythema. However, 
they are ineffective in modulating PUV A-induced erythema. 
Therefore, it is probable that subsunces other th:m products of the 
cyclooxygenase pathway, i.e., prostanoids. are acting as mediators 
of this type of inflammation. 
The complement system is one of the most important effector 
systems of inflammation. The fact that, in the past, numerous pho-
totoxic substances have been shown to promote their phototoxic 
effects by a photoactivation of the complement system led us to 
hypothesize that complement activation may be a common causa-
tive faCtor in the pathogenesis of phototoxic cutaneous responses. 
Our hypothesis was that PUV A phototoxicity might also be me-
diated by activated complement components. This concept was 
supported by the earlier observation of complement activation after 
PUVA in suction blister fluid of the irradiated skin [2J. 
In the following experiment, the effects of PUV A on the com-
plement system in normal human serum and on polymorphnuclear 
leukocytes (PMN) were analyzed. Funhermore, the development 
of PUV A-induced phototoxiciry was studied in normal and C3-de-
ficient guinea pigs. LesionaJ skin of the guinea pigs was examined 
immunohistologically for evidence of C-activation. 
MATERIALS AND METHODS 
Animals The studies were performed on ourbred Hartley strain 
albino female guinea pigs ranging in weight from 350 to 500 g and 
possessing an unimpaired complemelU system. In parallel experi-
ments, white inbred guinea pigs genetically deficient in C3 were 
used [3J. Congenic guinea pigs from the parental C3-competent 
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inbred srrain served as controls. All animals had free access ro water 
and standard laboratory food. 
Lig ht Source The animals received irradiacion from a PUV A 
4000 lamp (Waldmann. Villingen-Schwenningen. FRG). which 
has an emission spectrum of 320-390 nm with a maximum at 
365 nm. The output at wavelengths shorter than 320 nm was 
blocked by UVB and UVC filters. The distance from the light 
source to the target was 25 em. UV light irradianee was measured 
with a thermopyle (Kipp and Zonen. Delft. Holland). 
PUV A T reatment At the dorsal surface of each animal an area of 
6 X 6 cm was shaved with electric shears. We minimized the possi-
ble effect of irritation from shaving by performing PUV A treat-
ments 24 h after shaving. The dorsal surface was divided into four 
areas, each measuring 3 X 3 cm. One area was used for each of the 
following treatments: PUVA. UVA only. B-MOP only. and un-
treated control. 
A 0. 15% solution ofB-MOP (Meladinine. Basotherm. Biberach. 
FRG) was applied topicaJly on the right side (6 X 3 cm) of the 
shavcd back (20 " I/cm' skin surfaco) 45 min before UVA. The left 
side remained without 8-MOP trearment. The caudal half of the 
shaved area was covered with light occlusive tape. The cranial part 
was irradiated with UV A in total single doses ranging from 1 to 10 
J/cml. Both C3-deficient animals and C3-competent controls re-
ceived a single dose of5 J/cml UVA,a dose which was erythrogenic 
in nonnal oucbred guinea pigs. 
At I, 24, 48 and 72 h after UV A exposure, erythema was graded 
on a semiquantitative scale from 0 to ++++. Punch biopsy speci-
mens (5 mm diameter) were taken from each area I, 2, 3, 5, 7, and 
up to 12 d after treatment. The specimens were snap-frozen in 
melting isopentan, cooled by liquid nitrogen, and stored at -80·C 
until they were used for immunohistologic examination. 
Immunohistologic T echniques 5 J1.m th ick cryostat sections cut 
at -20 G C were placed on microscope slides, ai r dried, and fixed in 
acetone. AP AAP staining was performed according ro the method 
of Cordell 14]. Briefly, sections were incubated overnight with 
monoclonal antibodies to guinea pig C3 described previously [5]. 
Ascites diluted 1: 80 or 1: 400 was used as the sourCe of antibody. 
The sections were rinsed in PBS, pH 7.4, then incubated with the 
bridging antibody (rabbit anti-mouse IgG I : 25. Dakopa",. Copen-
hagen. Denmark) for 25 min. After being washed again in PBS, 
sections were incubated with the APAAP complexes (Dakopatts, 
t : 10 diluted). Alkaline phosphatase was visualized by fast red 
method. 
Biotin-streptavidin-peroxidase staining was performed as pre-
viously described [6], with polyclonal rabbit antibodies to human 
C3c, C3d, and C4 which had been shown to react predominantly 
with tissuc bound C3b. C3d-g/C3d. or C4d. respectively (Dako-
paus, diluted 1 : 400; the specificity towards guinea pig antigens was 
confirmed by dotblot analysis, Ouchterlony, or ELISA). After incu-
bation for 30 min, sections were washed in PBS, incubated with a 
biotin goat anti-rabbit antibody (1 : 400 diluted; Dianova, Ham-
burg, FRG), again rinsed in PBS, then incubated with streptavidin-
peroxidase (1 : 400; Amersham-Buchler. Braunschweig, FRG), and 
finally stained with 0.5 mg/ml diaminobenaidine (Fluka. Buchs. 
Switzerland) and 0.0 12% H,O,. Binding of the rabbit anti-C3d and 
-C3c antibodies was visualized, in parallel. by the ABC-technique 
(Camon/Vector, Wiesbaden, FRG). In these sections, antibody 
unrelated biotin binding sites of the tissue had been blocked by :I. 
biotin blocking kit (Camon/Vector. Wiesbaden. FRG). 
Additionally, a portion of each biopsy s~cimen was stained with 
hematoxylin eosin and periodic-acid-Schiff. Sections were mounted 
in buffered glycerol and examined under light microscope (Zeiss, 
Frankfurt. FRG). Photomicrographs were taken on a Kodak Ek-
tachrome, 50 ASA, at a final magnification of X 100. 
In Vitro Irradiation of Human Serum and Complem ent 
Assays 8-MOP pure substance (Basotherm, Biberach, FRG) was 
added to normal human serum at a final concentration of 0.1 or 1 
mM/I. respectively. The test tubes were wrapped in tin foil to 
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minimize the effect of ambient ultraviolet irradiation, and cooled 
on ice. 
60 min later, sera were transferred to petri dishes, placed on ice at 
a distance of 25 cm from the light source, and irradiated in doses 
from 5 to 30 J/cm2• To evaluate the effect of UVA only, normal 
human serum was irradiated in parallel in the absence of 8-MOP. 
Other aliquots containing 8-MOP were not exposed to UVA. Neg-
ative comrols received neither 8-MOP nor UVA. Complement 
activation of the positive controls was induced by addition of 25 
mg/ml zymosan to norma) human serum and incubation for 60 min 
at 37"C. 
After irradiation, samples were incubated in darkness at 4·C or 
3rC, respectively. At different time intervals, i.e., 1,2,4,24, and 
48 h after irradiation, aHquots were taken from each sample. To 
each aliquot a stock solurion (0.1 M/I Na, EDTA. pH 7.2) was 
added to give a final concentration of 0.0 1 Mil EDTA to stop 
further C activation. Aliquots were snap-frozen in liquid nitrogen 
and stored at -80·C. 
Normal human serum from the same healthy donor as above was 
treated as mentioned with PUVA, 8-MOP, or UVA hefore or after 
C-activatioll by four different methods [7]: incubation for 120 h at 
37 G C. or the addition of zymosan, MgCII' or aggregated IgG, 
respectively. In the untreated controls, each mode of activation 
resulted in a defined cleavage of C3 (40%-80%. respectively) as 
shown by two-dimensional crossed immunoelectrophoresis (XlE). 
XIE was performed according to Laurell [8] with modifications 
suggested by W ceke [91 in 1% aguose on lOX IO-cm glass slides. 
Rabbit antiserum to human C3c and C3d was purchased from Da-
kopatts and was present at concentration of 0.75 and 1.5 pl/cml , 
respectively, in the gel during the second dimension. 
For C3a measurements, a commercially available RIA test Itit was 
used (Amersham-Buchler, Braunschweig, FRG) applying the 
above-mentioned zymosan activated serum as posi tive control. 
In Vitro irradiation of PMN PMN were obtained from veuous 
blood of healthy .dult donors by thc method described by Haslett. 
Guthrie. Kopaniak et al (10[. Briefly. PMN were isolated by a 
plasma-percoll gradient technique, washed in platelet poor plasma 
and HBSA. and adjusted to 2- 5 X 10' cells/ml. This final prepara-
tion contained 90-95% neutrophils. Viability was higher than 95% 
as assessed by trypan blue exclusion ass:l.y. 
8-MOP was diluted in DMSO to givea final concentrationof1 or 
10 "g/ml in the culrure medium. i.e .• 4.63 "M/I or 46.26 " M/I. 
res~ctively. Final concentration of DMSO never exceeded 0. 1 % 
(v/v). After incubation in dark.ness for 60 min at room temperature, 
cells were transferred to petri dishes and irradiated with UVA in 
doses from 3 to 5 J/cml. Other samples were only exposed to UV A 
or to 8-MOP, respectively. Controls remained untreated. After irra-
diation, exposure of the cells to UVA was kept to a minimwu. 
The trypan blue dye exclusion test of viability was performed first 
1 h after PUV A treatment and again after an additional incubation 
period of 24 h at 37"G. 
A part of the cells was centrifuged after PU VA, resuspended in 
normal human serum 1: 2 diluted by HBSA, and incubated for 15 
min at 37 G C. Supernatants of these cells were ex.amined for evi-
dence of C3-activation by a C3a RIA (Amersham). The cells and tbe 
pellets were washed in HBSA and stained by conventional immuno-
fluorescence technique with FITC-Iabeled polyclonal antibodies to 
C3c (Dakop.tts. Copenhagen. Denmark. in • dilution of I : 30 with 
PI3S). Lactic dehydrogenase in the supernatants was measured with 
sodium pyruvate as substrate. Elastase release was assayed according 
to the met bod ofBieth, Spiess, and Wermuth [11J with succinylni-
troaniJid as substrate (Sigma, Deisenhofen, FRG). Supernatants of 
cells lysed by TritonX100 served as positive control for both LDH 
and elastase assay. Specific release was expressed as calculated ac-
cording to the following formula: 
x, 
release in experiments - background release 
total positive control - background release' 
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RESULTS 
In Vitro Irradiation of Serum To invesdgate whether PUVA 
could induce a direct activation of serum complement, we analyzed 
i<s e/feC[ 011 C3 by XlE, varying both UVA dosage and 8-MOP 
concentrat ion. A representative result of several experiments is 
shown in Fig 1. There were no significanc differences in immuno-
electrophoretical C3-conversion between PUVA. UVA only-. and 
8-MOP only-treated. and untreated sera. XlE of all samples incu-
bated at 37°C for various times showed additional extra-anodal 
precipitation peaks representing cleavage products of C3, i.e. , C3b, 
C3c, and C3djC3d-g. No C-activarion occurred in samples incu-
bated at 4°C, Addition of 8-MOP and/or exposure to UVA alone 
did not aIrer these effects. The positive control (zymosan) revealed 
an 80 ± 2% (mean ± SD) cleavage of C3. 
C activation induced in normal human serum at 37°C by zymo-
san, IgG-aggregares, MgCI 2 • or prolonged incubation was, furth er-
more, nor modulated by the addi tion ofS-MOP or UVA irradiatio n 
or by PUVA before treatment or thereafter (data nO[ shown). 
Sera were examined in parallel for evidence of C activation by 
C3a-RIA. The C3a concentrations of all sera were in the normal 
range (Table I), Addirion of 8-MOP and/or UVA irradiation did 
not enhance C3a generation in se rum or EDTA-plasma. Positive 
comrol (zymosan) showed about 82 ± 3% of maximal C3a genera-
tion. 
In Vitro Irradiation ofPMN Assessment of leukocyte viabilicy 
by means of trypan blue exclusion revealed that cell viability was not 
I 
I 
I 
~ 
I 
~ 
I 
I 
I 
I 
a 
I 
I 
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Figure 1. Crossed immunoelectrophoresis of (a) PUVA-treatcd (1 mM 
8-MOP: 5 JJcm2 UV A) and (b) untreated normal human serum. Anode left. 
Arrows point to the positions of unclcaved C3 (big arrow). C3b (tiltlt arrow). 
and C3d (arro lu with dotted line). No differences in C3 conversion were 
observed. 
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Table I. C3a Release in NHS After PUVA Treatment 
NHS + 8-MOP- + UVA' 
NHS +8-MOP-
NHS + UVA' 
NHS untreated 
Ncgarivc controls 
Plasma' + B-MOP"' + UVA· 
Plasma' + B-MOP"' 
Plasma' + UVA· 
Plasma~ untreated 
C3a (ng/ml) 
432 
S04 
456 
468 
218 
222 
216 
222 
• 8-MOP added 45 min prior to UVA ,It final concentration of t X 10- ) MIL 
• Samples irradiated with 30 J/cm2 UVA. 
• plasma contaimng 10 mM/ 1 EDTA. 
affected even ar high concemratio ns ofB-MOP (10 ng/ml) and/or 
high UVA dosage (5 J /cm2). Viability 1 h after irradiation was 
between 95% and 100% in all samples (Table II). After an incuba-
tion period of 24 h at 37°C, the ability of 8-MOP and/or UVA-
treated leukocytes to exclude the dye was only slightly diminished, 
i.e., neither PUVA, UVA, nor 8-MOP had any direct or prolonged 
effect on PMN viability. The extent of LDH release was similar in 
all four tested groups. 
Elastase release of PMN was not nocably affecred as well by 
PUVA, UVA, or 8-MOP, as compared to the untreated controls. 
Supernarants of ce lls which had been incubared wirh NHS afrer 
PUV A rreatment showed no significanr C3a generation and did not 
differ in this respect from the orher three groups (8-MOP, UVA, or 
untreated cells). Direct immuno fluorescence did not reveal any C3b 
or C3d deposition on the surface of the PMN in either groups. 
In Vivo Stud ies PUVA treatmenr of normal guinea pigs resulted 
in the development o f erythema 24 h after irradiation with a maxi-
mum at 48 h (Fig 2). C linica l changes were associated with acan-
thosis and the appearance of necrotic kerarinocytes (sunburn cells) 
between 2 and 5 dafter PUV A as shown by histologic examination 
(Fig 3a' ). Immunohistologic staining consistenrly demonstrated de-
posits of C3-rclared antigens (Fig 3a) and C4d (not shown) on 
necrotic keratinocytes. C3d/C3d-g was similarly preseor at those 
sites. C3-related aorigen deposirion could be visualized by borh 
techniques, i.e., by the polyclonal antibodies and rhe ABC tech-
nique and by monoclonal antibodies against C3 and the APAAP 
method. 
At sites only rreated either with UVA (Fig 2b) or 8-MOP (Fig 2c), 
respecriveiy, no visible changes, such as eryrhema, were nored. His-
rologic and immunohisrologic examination of these areas showed 
non nal epidermis and dennis (Fig 3e, c'). 
Similar responses to PUVA were elicited in inbred guinea pigs 
congcnitally deficient in C3 and in comrol animals from the con-
genic C3-competent inbred strain. Delayed eryrhema was identical 
in imcnsiry and time course. Histologic examination revealed simi-
lar findings as in the outhred animals: acanthosis, blistering, and 
necroric keratinocytes were demonstrable between the second and 
the fifth day in both groups of animals. 
Immunoh isrologic findings in PUVA-treated skin , however , 
were quite different in C3-deficient guinea pigs. As shown in Fig 3, 
deposits of C3-related antigens (Fig 3b) were complerely absent, 
while the ex ten t of acanthosis and necrosis ofkerarinocytes (Fig 3b') 
was similar to that found in the PUVA-rreated areas of C3-compe-
ten t an imals. 
DISCUSSION 
T he results of the present srudy show thar rhe cutaneous phototoxic 
reaction following PUVA treatmCnt develops inderendenr of the 
complement system. W e analyzed the question 0 a possible in-
volvemenr of complement by four independent approaches: (1) the 
direct effect of PUV A on C3 convers ion in fresh human se rum; (2) 
the modularing effects of PUVA on various rypes of ongoing C 
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Table H. Viability and Elastase and LDH-Rdease ofPMN's Following PUVA-Treatment 
Viability LDH Elastase 
8-MOP UVA 
Group lO~g/ml 5 ) Icm' 1 h 
I + + 99 
II + 95 
III + 99 
IV 98 
activation in vitro; (3) the indirect effects of PUV A on serum com-
plement via activation or damage of PMN, and (4) the development 
of PUV A-induced erythema and immunohistologic alterations of 
the skin in C3-deficient and C3-competent guinea pigs. 
Measuremem of C3 cleavage or its modulation was assayed by 
crossed immunoelectrophoresis and C3a-R1A. In rdated studies of 
UV exposure, C3-cleavage products were detected by XlE in nor-
mal human serum containing demcthyltetracycline [12], chloro-
thiazide [131 or chlorpromazine [14J. thus indicating C activation. 
UV irradiation of sera from patients with crythropoetic porphyria 
and porphyria cutanea tarda. as well as local in vivo UV irradiation 
of patients with porphyrias. resulted in C3 conversion in XlE 
113,15j. XlE would have been sensitive enough to detect as little as 
5% conversion of serum C3 in our hands (interassay variance < 4%; 
data nOt shown). Our observations were corroborated by the highly 
sensitive C3a-RIA as a second test method to confirm C3 cleavage. 
However, in our measurements there was no evidence for C 
activation in PUV A-treated serum as compared to UV A-treated, 
8-MOP-treatcd and untrcated serum even at high 8-MOP concen-
trations and over a wide range of UVA dosages. To investigate 
whether PUVA modulates an ongoing C activation in vitro, we 
induced complement activation before and after PUVA and mea-
sured C3 cleavage by XIE. PUVA did not result in potentiation or 
inhibition of C3 cleavage irrespective of the type of C activation. 
Since a direct serum-C activation in a cell-free environment was 
ruled out, we analyzed the PUVA-induced release of C3-c1eaving 
enzymes from PMN. The extent of PMN activation in vitro is 
correlated with the amount of granulocyte-elastase released into the 
supernatant [161. The known potency of granulocyte-derived elas-
tase to cleave and activate C3 suggests that liberation of this enzyme 
is the cause of antibody-independent C3 activation in vivo, which is 
observed in various types of inflammation [17J. LDH concenrration 
in the supernatant and the dye exclusion tests are good parameters 
Figure 2. Erythema 72 h after local treatment with (tI) PUVA (8-MOP 
[opically: 5 ) Icm' UVA), (b) UVA (simil" do .. ), oc (,) 8-MOP. (d) Un-
treated control. An erythema was elicited exclusively in and limited to the 
PUVA-tre:ued area. 
(%) (% spec. release) (% spec. release) 
24 h 1 h 1 h 24 h 
86 0 0 1 
86 16 0 3 
84 0 11 4 
92 0 I 10 
Figure 3. I)aired photomicrographs (ltfi sidt: immunohistologic staining; 
rigl!/ sidt: phase COntrast image t2ken in pal1lllel) of guinea pigskin specimens 
after st2ining for tissue bound C3-related antigens (ABC peroxidase tecb-
nique. rabbit anti·C3c). (tI) PUVA-tre:ued (8-MOP topicall),; 5 J/ cm2 UVA) 
normal guinea pigs revealed remarkable deposits of C3-related antigens on 
necrotic keratinocytes. Note the acanthosis and extensive formation of in-
traepidermal small blisters (tI'). C3-related antigens were absent (b) in the 
similarly damaged epidermis (b') of the C3-deficient animals. In UVA-
treated gp skin no immunohistologic changes were noted. neither in normal 
(t/t') nor in C3-defieient gp (d/d'). Magnification of all micrographs. X 120. 
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for measuring damage and/or viability of PMN, respectively (18J. 
However, in our study neither LDH nor elastase from PMN nor 
PMN viability was affected by PUVA. 
We had focused our am:ntion on viabiliry and on deposition of 
C3 On PMN because damaged or necrotic cells are capable of activa-
tion of the complement system via the alternative puhway [19]' 
OUf experiments with PUV A-treated PMN which were subse-
quently incubated with serum for detection of such delayed C acti-
vation were completely negative. Similarly, the C3a-assay failed to 
deccC[ any C3-cleavage under those conditions. Our negative find-
ings arc mostly consistent with recent observations of other investi-
gators in which PUVA did not remarkably affect the viability or 
biologic (uncdons of PMN in vitro and in vivo [20-241. 
The most convincing evidence for a complement independence 
of PUVA phototoxicity was obtained in our study by PUVA treat-
mem of guinea pigs congenitally deficient in C3[3]. Those animals 
developed phototoxic dermatitis after PUV A identical in time 
course and intensity to that of normal congenic C3 competent con-
trol animals. 
These findings contrast with the skin reactions occurring with 
other exogenous or endogenous pho[otoxic reagents in decomple-
memed animals. Phototoxic reactions induced by demethyltetracy-
cline. hemacoporphyrin, and chlorpromazin were markedly sup-
pressed in cobra venom factor decomplemented guinea pigs as 
compared to comrol animals, indicating that an imact complement 
system is required for the full development of these types of photo-
toxic reactions rt2.14,2SI. 
In our experiments, histologic changes after PUV A, i.e., acan-
thosis, necrosis of keratinocytes were identical in C3-deficient and 
nonnal guinea pigs. However, deposits of C3 metabolites (predomi-
nantly C3d) as demonstrated by inunutlohiscology were exclusively 
on necrotic keratinocytes of C3-competent guinea pigs. The pres-
ence of a fully developed PUVA erythema and its typical pathohis-
cologie features in the absence of C3 deposits (in the C3-deficiem 
animals) is consistent with C3 activation and deposition of C3d in 
normal guinea pigs occurring primarily as an epiphenomenon. 
These changes might be induced by the necrosis of keratinocytes or 
could be the result of a PUV A-induced alteration to glycoproteins 
on keratinocyte surface membranes {26]. 
The absence of immunoglobulin or complement ;'C3" deposits 
in the skin ofPuv A-treated patients has also been reported by other 
laboratories [27,28]. We had the chance to examine one skin biopsy 
taken from a psoriatic patient after development of a PUV A ery~ 
thema. We failed to detect any indication of local C activation when 
we stained the skin biopsy for Clq, C4b, C4d. C3b, C3d, faCtor H, 
factor p. CS, C9, and CSb-9-neoantigens using both direct immu-
nofluorescence or monoclonal antibodies in the APAAP method 
(data not shown). Recently "e3" deposition at the denno-epider-
mal junction and around the upper dermal vessel was rep?rted by 
others in seven patients developing blisters after PUVA 129J. The 
authors suggested it was unlikely that C activation had mediated the 
epidermal damage because no accumulation of ncucrophils accom-
panied C deposition. We have examined a biopsy specimen taken 
from a blister occurring 12 h after local PUVA therapy in a patient 
with an eczema and an increased sensitivity to UV A irradiation. 
Immunohistologic examination demonstrated remarkable IgM and 
complement deposits (predominantly C4d, C3d, C3b, factor H , and 
CSb-9 complexes) on the necrotic keratinocytes and in the upper 
dennal vessels (Fig 4). These findings confirm that complement 
activation and immunoglobulin deposition, which arc absent in 
PUVA erythema. can occur in association with more severe photo-
toxic tissue damage, such as blister formation. 
The pathogenic role of complement in PUVA blister formation 
needs to be clarified by future studies. Comrlemcnt activation seems 
nO[ to be essential for the development 0 the PUV A-induced de-
layed erythema. Further studies will have to elucidate whether 
other potent mediators (such as eicosanoids, platelet activating fac. 
tor, metabolites of keratinocytes. or cytokines) are involved in ery-
thema formation after PUV A treatment. 
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Figure ... Direct immunofluorescence staining of a biopsy s~eimen from a 
blim:r occurring 12 h after local PUVA (a-MOP topical1y; 0.5 J/cm2 UV A) 
in a patiem with an eczema. Heavy C3d deposits were!reseO[ on necrotic 
keratlnocytes in the blister roof and bottom and aroun su~rficial dermal 
vessels. Magnification. X 100. 
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